PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 12075697

Interventional endosonography.

Irving Waxman·Charles E Dye
View original source ↗Export metadata ↓

Abstract

Endoscopic ultrasound (EUS) has become the most accurate imaging modality for locoregional cancer staging of the gastrointestinal (GI) tract. Fine-needle aspiration (FNA) capabilities have added a whole new level of accuracy in nodal staging with reported numbers in the 90% range for luminal and pancreaticobiliary disease. In addition, new non-GI applications are being evaluated like the role of EUS-FNA for non-small cell lung carcinoma and exploration of the posterior mediastinum. Furthermore, the same capabilities that allow for safe tissue sampling are being explored for interventional applications like EUS-guided celiac plexus neurolysis and fine-needle injection. The following review describes the current clinical status of EUS in GI oncology as well as future and novel indications and therapeutic strategies for this technology.

Explore related subjects

Biopsy, NeedleDigestive System NeoplasmsEndosonographyHumansNeoplasm StagingUltrasonography, InterventionalVideo-Assisted SurgeryJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Irving Waxman, Charles E Dye. Interventional endosonography.. https://pubmed.ncbi.nlm.nih.gov/12075697/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

KOC is a novel molecular indicator of malignancy.

The detection of malignant cells in fine-needle aspirates (FNA's) using marker genes is hampered by the fact that these markers are only expressed by certain malignancies or lack sensitivity and/or specificity. Here we report the results of a prospective pilot study examining the expression of KOC (KH-domain containing protein over expressed in cancer), a novel onco-foetal gene, in 76 patients who underwent fine-needle aspiration for further diagnosis of abdominal lesions, aszites, cysts or cerebrospinal fluid. Aspirates were examined by cytology and by a KOC RT-PCR assay. KOC expression was a highly sensitive and specific indicator of malignancy. The KOC assay could be useful to facilitate screening for malignant disease and to improve the diagnostic accuracy of FNAs.

Biopsy, Needle↗
PubMed2003

Natural history of benign solid and cystic thyroid nodules.

BACKGROUND: Thyroid nodules are common and most often benign. The natural history of benign thyroid nodules, however, is unclear. OBJECTIVE: To determine the natural history of cytologically benign thyroid nodules using ultrasonography. DESIGN: Retrospective case series. SETTING: Single tertiary care clinic. PARTICIPANTS: All patients referred to the Brigham and Women's Hospital Thyroid Nodule Clinic, Boston, Massachusetts, who had benign cytologic results on ultrasonography-guided fine-needle aspiration of a thyroid nodule between 1995 and 2000 and returned for a requested follow-up examination 1 month to 5 years later. MEASUREMENTS: Nodule dimensions were measured at both visits, and growth was defined as an increase in calculated volume of 15% or greater. These results were correlated with the time between examinations, age, sex, baseline serum thyroid-stimulating hormone concentration, and cystic content of each nodule. RESULTS: Nodule volume increased over time (P < 0.001). The estimated proportion of nodules with an increase in volume of 15% or greater after 5 years was 89%. Nodules with greater cystic content were less likely to grow than solid nodules (P = 0.01). Seventy-four of the 330 nodules were reaspirated on the second visit. Despite an average increase in volume of 69%, only 1 of 74 reaspirated nodules was malignant. CONCLUSION: Most solid, benign thyroid nodules grow. Therefore, an increase in nodule volume alone is not a reliable predictor of malignancy.

Biopsy, Needle↗